Salona Global Medical Device Corporation
Simbolis: SGMD.V
TSX
0.22
CADRinkos kaina šiandien
-15.8062
P/E santykis
0.2483
PEG koeficientas
17.24M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Salona Global Medical Device Corporation (SGMD-V) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 0 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 0 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 0 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | 2.5 | -7.1 | -8.3 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | 0 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | 0 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -3.8 | -1 | -0.1 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 0 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | 0 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | 0 | -4.4 | -2.7 | -2.3 |
Dažnai užduodami klausimai
Kas yra Salona Global Medical Device Corporation (SGMD.V) bendras turtas?
Salona Global Medical Device Corporation (SGMD.V) bendras turtas yra 42681612.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.357.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -0.015.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra -0.023.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra -0.080.
Kas yra Salona Global Medical Device Corporation (SGMD.V) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra -4372019.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 10533056.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 6570013.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.